Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

BACKGROUND: S‐1 monotherapy is effective and feasible for previously treated patients with advanced non‐small cell lung cancer (NSCLC). However, it is not clear whether its effectiveness and tolerability in elderly patients are equivalent to those in younger patients. Hence, this study aimed to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Minemura, Hiroyuki, Kishikawa, Takayuki, Yamada, Yutaka, Suzuki, Kensuke, Umeda, Yukihiro, Wasamoto, Satoshi, Kasahara, Norimitsu, Ishihara, Shinichi, Yamaguchi, Ou, Naruse, Ichiro, Uchino, Junji, Mori, Keita, Kanazawa, Kenya, Shibata, Yoko, Kasai, Takashi, Kaburagi, Takayuki, Kaira, Kyoichi, Minato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529563/
https://www.ncbi.nlm.nih.gov/pubmed/32844570
http://dx.doi.org/10.1111/1759-7714.13622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529563/
https://www.ncbi.nlm.nih.gov/pubmed/32844570
http://dx.doi.org/10.1111/1759-7714.13622

Ejemplares similares